Hartford Great Health (HFUS) 10-K 14 Nov 18 2018 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Jul. 31, 2018	Nov. 14, 2018	Jan. 31, 2018
Equity Issuance Dollar Amount Per Share Duration One
Document Type	10-K
Amendment Flag	false
Document Period End Date	Jul. 31, 2018
Entity Registrant Name	Hartford Great Health Corp.
Entity Central Index Key	1,482,554
Current Fiscal Year End Date	--07-31
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,018
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	true
Entity Small Business	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		3,018,000
Entity Public Float			$ 0
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes

BALANCE SHEETS

BALANCE SHEETS - USD ($)	Jul. 31, 2018	Jul. 31, 2017
Current assets:
Cash and cash equivalents	$ 1,444	$ 1,928
Total current assets	1,444	1,928
Fixed Assets
Computer equipment	2,792	2,792
Accumulated depreciation	(2,792)	(2,262)
Net book value	0	530
Total assets	1,444	2,458
Current liabilities:
Accounts payable	832	2,191
Accrued Interest to stockholders	0	237
Advances from stockholders	0	21,180
Total current liabilities	832	23,608
Total liabilities	832	23,608
Stockholders' equity (deficit):
Preferred stock - $0.001 par value, 5,000,000 shares authorized: No shares issued or outstanding	0	0
Common stock - $0.001 par value, 100,000,000 shares authorized: 3,018,000 shares issued and outstanding	3,018	3,018
Additional paid-in capital	330,241	283,113
Accumulated (deficit)	(332,647)	(307,281)
Total stockholders' equity (deficit)	612	(21,150)
Total liabilities and stockholders' equity (deficit)	$ 1,444	$ 2,458

BALANCE SHEETS (Parenthetical)

BALANCE SHEETS (Parenthetical) - $ / shares	Jul. 31, 2018	Jul. 31, 2017
Statement of Financial Position [Abstract]
Preferred stock, par value per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value per share	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	3,018,000	3,018,000
Common stock, shares outstanding	3,018,000	3,018,000

STATEMENTS OF OPERATIONS

STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Jul. 31, 2018	Jul. 31, 2017
Income Statement [Abstract]
Revenues	$ 0	$ 0
Operating expenses:
Website development	3,385	2,193
Legal and accounting fees	13,542	11,138
Investor relations	7,746	4,868
Other general and administrative	400	483
Depreciation Expense	530	933
Total operating expenses	25,603	19,615
Operating (loss)	(25,603)	(19,615)
Other income(expense):
Interest expense	237	(237)
Other income (expense) net	237	(237)
Net (loss)	$ (25,366)	$ (19,852)
Net (loss) per common share: Basic and Diluted	$ (0.01)	$ (0.01)
Weighted average shares outstanding: Basic and Diluted	3,018,000	3,018,000

STATEMENTS OF CASH FLOWS

STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Jul. 31, 2018	Jul. 31, 2017
Cash flows from operating activities:
Net (loss)	$ (25,366)	$ (19,852)
Adjustments to reconcile net (loss) to net cash used by operating activities:
Impairment	0	0
Depreciation	530	933
Stock issued for services	0	0
Changes in operating assets and liabilities:
Increase/(decrease) in accounts payable	(1,359)	(929)
Increase/(decrease) in accrued interest to stockholders	(237)	237
Increase/(decrease) in advances from officer	0	0
Net cash (used in) operating activities	(26,432)	(19,611)
Cash flows from investing activities:
Net cash (used in) investing activities	0	0
Cash flows from financing activities:
Capital contributions from stockholders	25,948	0
Loans from stockholders	0	21,180
Net cash provided by financing activities	25,948	21,180
Net increase (decrease) in cash and equivalents	(484)	1,569
Cash and equivalents at beginning of period	1,928	359
Cash and equivalents at end of period	1,444	1,928
Supplemental Cash Flow Information
Interest paid	0	0
Income taxes paid	0	0
Non-cash investing and financing activities	$ 0	$ 0

STATEMENT OF CHANGES IN STOCKHO

STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Common Stock	Additional Paid - in Capital [Member]	Accumulated (Deficit) [Member]	Total
Balance at Jul. 31, 2016	$ 3,018	$ 283,113	$ (287,429)	$ (1,298)
Balance, shares at Jul. 31, 2016	3,018,000
Net (loss)			(19,852)	(19,852)
Balance at Jul. 31, 2017	$ 3,018	283,113	(307,281)	(21,150)
Balance, shares at Jul. 31, 2017	3,018,000
Additional paid in capital		47,128		47,128
Net (loss)			(25,366)	(25,366)
Balance at Jul. 31, 2018	$ 3,018	$ 330,241	$ (332,647)	$ 612
Balance, shares at Jul. 31, 2018	3,018,000

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Jul. 31, 2018
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES This summary of significant accounting policies is presented to assist in understanding the Company's financial statements. The financial statements and notes are the responsibility of the Company's management. These accounting policies conform to accounting principles generally accepted in the United States of America ("US GAAP") and have been consistently applied in the preparation of the financial statements. Organization Hartford Great Health Corp. (the "Company" or "Hartford Great Health Corp.") was organized under the laws of the State of Nevada on April 2, 2008. The Company has not yet realized revenues from its planned operations. Its plan was to develop photographic sharing and networking through its website PhotoAmigo.com. The Company has chosen July 31 as its fiscal year-end. Use of Estimates The preparation of financial statements in conformity with US GAAP requires the Company's management to make estimates and assumptions that affect the amounts of assets and liabilities, the identification and disclosure of impaired assets and contingent liabilities at the date of the financial statements, and the reported amounts expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents For purposes of balance sheet classification and the statements of cash flows, the Company considers cash in banks, deposits in transit, and all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of temporary cash investments. On July 31, 2018, the Company did not have a concentration of credit risk since it had no temporary cash investments in bank accounts in excess of the FDIC insured amounts. Fair Value of Financial Instruments Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of July 31, 2018 and 2017. These financial instruments include cash, accounts payable, and advances from officers. Fair values are assumed to approximate carrying values for these financial instruments because they are short term in nature, or are receivable or payable on demand. Capital Expenditures Expenditures for capital assets are recorded at historical cost. Additions, improvements and major renewals are capitalized, while maintenance, repairs and minor renewals are expensed as incurred. When assets are retired or disposed of, the assets and related accumulated depreciation and amortization are removed from our general ledger, and the resulting gain or loss is reflected in the statement of operations. Depreciation of capital assets is provided over their estimated useful lives on a straight line basis Impairment of Long Lived Assets Hartford Great Health Corp. periodically reviews the carrying amount of long lived assets to determine whether current events or changes in circumstances warrant adjustments to such carrying amounts. If an impairment adjustment is deemed necessary, such loss is measured by the amount that the carrying value of such assets exceeds their fair value. Considerable management judgment is necessary to estimate the fair value of assets; accordingly, actual results could vary significantly from such estimates. Assets to be disposed of are carried at the lower of their financial statement carrying amount or fair value less costs to sell. Income Taxes Deferred income taxes are recorded for timing differences between items of income or expense reported in the financial statements and those reported for income tax purposes using the asset/liability method of accounting for income taxes. Deferred income taxes and tax benefits are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and for tax loss and credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company provides for deferred taxes for the estimated future tax effects attributable to temporary differences and carry-forwards when realization is more likely than not. If the Company concludes that it is more likely than not that some portion or all of the deferred tax asset will not be realized, the balance of deferred tax assets is reduced by a valuation allowance. Revenue Recognition Hartford Great Health Corp. recently commenced operations and has not yet generated revenues from operations. Revenues was expected to be derived principally from subscriptions to our website. In accordance with established guidance, Hartford Great Health Corp. plans to recognize revenue when the price is fixed or determinable, persuasive evidence of an arrangement exists, the service is performed and collectability of the amount is reasonably assured. Certain insignificant amounts collected during the development, testing, and implementation phases are recorded as a recovery of development expense. Advertising costs Advertising costs are expensed as incurred. No advertising costs were incurred during the twelve month periods ended July 31, 2018 or 2017. Stock-based Compensation Hartford Great Health Corp. has no stock compensation plan and has not made any grants since inception, and, accordingly, has not recognized any stock-based compensation expense. Hartford Great Health Corp. plans to account for stock-based compensation in accordance with the fair value recognition provisions of US GAAP. Stock based compensation will be measured at the grant date based upon the estimated fair value of the award and the expense will be recognized over the required employee service period. The fair value of restricted stock grants will be estimated on the grant date based upon the fair value of the common stock. Income (Loss) Per Share Basic earnings per share includes no dilution and is computed by dividing net income (or loss) by the weighted-average number of shares outstanding during the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of the Company, assuming the issuance of an equivalent number of common shares pursuant to options, warrants, or convertible debt arrangements. Diluted earnings per share is not shown for periods in which the Company incurs a loss because it would be anti-dilutive. Similarly, potential common stock equivalents are not included in the calculation if the effect would be anti-dilutive. Since inception, Hartford Great Health Corp. has not issued any potentially dilutive securities. During the twelve months ended July 31, 2018 and 2017, no potentially dilutive debt or equity instruments were issued or outstanding. Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results operations.

GOING CONCERN

GOING CONCERN	12 Months Ended
	Jul. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	NOTE 2. GOING CONCERN The accompanying financial statements were prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of obligations in the normal course of business. However, Hartford Great Health Corp.'s operations has incurred losses since inception, resulting in an accumulated deficit of $332,647 as of July 31, 2018. These conditions raise substantial doubt about the ability of Hartford Great Health Corp. to continue as a going concern. In view of these matters, continuation as a going concern is dependent upon several factors, including the availability of debt or equity funding upon terms and conditions acceptable to Hartford Great Health Corp., and ultimately achieving profitable operations. Management believes that Hartford Great Health Corp.'s business plan provides it with an opportunity to continue as a going concern. However, management cannot provide assurance that Hartford Great Health Corp. will meet its objectives and be able to continue in operation. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of Hartford Great Health Corp. to continue as a going concern.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	12 Months Ended
	Jul. 31, 2018
Stockholders' equity (deficit):
STOCKHOLDERS' EQUITY	NOTE 3. STOCKHOLDERS' EQUITY Preferred Stock Common Stock Issued and Outstanding Additional Paid In Capital During the twelve months ended July 31, 2018 and 2017, stockholders contributed $25,948 and $21,180, respectively. These contributions were made to fund the Company's ongoing operations and were converted to additional paid in capital at the end of 2018 in the amount of $47,128.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Jul. 31, 2018
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 4. INCOME TAXES Hartford Great Health Corp.'s deferred tax assets, valuation allowance, and change in valuation allowance are as follows: Period Ending Estimated NOL carry-forward NOL expires Estimated tax benefit from NOL and other tax benefits (20%) Valuation allowance Change in valuation allowance Net tax asset July 31, 2017 $ 307,280 2037 $ 61,000 $ (61,000 ) $ (4,000 ) $ - July 31, 2018 $ 332,647 2038 $ 66,000 $ (66,000 ) $ (5,000 ) $ - Income taxes at the statutory rate are reconciled to reported income tax expense (benefit) as follows: 2018 2017 Income tax benefit at statutory rate (20 %) (20 %) Deferred income tax valuation allowance 20 % 20 % Reported tax rate 0 % 0 % At this time, the Company is unable to determine if it will be able to benefit from its deferred tax asset. There are limitations on the utilization of net operating loss carry-forwards, including a requirement that losses be offset against future taxable income, if any. In addition, there are limitations imposed by certain transactions which are deemed to be ownership changes. Accordingly, a valuation allowance has been established for the entire deferred tax asset. Other temporary differences and estimated permanent differences are considered immaterial. Open tax years subject to examination by the IRS range from August 1, 2014 to the present. The Company has no uncertain tax positions.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Jul. 31, 2018
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS During the twelve months ended July 31, 2018, the Company converted prior borrowings of $47,128 from four stockholders to additional paid in capital. The stockholders have not received any equity for these advances from stockholders which were previously expected to be repaid by the Company. Under the terms of the arrangement, simple interest accrued on these advances at 2% annually but this was forgiven. Principal and interest were due upon the sale of the company or upon demand. Stockholders have forgiven $237 of accrued interest for the twelve months ended July 31, 2018 related to these advances. At the year-end date of July 31, 2018 there were $-0- advances from the stockholders and consequently there was no accrued interest related to these advances. Office space is provided to Hartford Great Health Corp. at no additional cost by the sole executive officer. No provision for these costs has been included in these financial statements as the amounts are not material. During the twelve months ended July 31, 2018 and 2017, stockholders contributed $25,948 and $21,180, respectively. These contributions were made to fund the Company's ongoing operations and have been credited to additional paid in capital.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Jul. 31, 2018
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 6. SUBSEQUENT EVENTS In accordance with ASC 855 , "Subsequent Events" The Company plans to issue 96,982,000 common shares value at $0.02 cents per share, in China, raising approximately $1.94 million in capital. There is no assurance that any money will be raised.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Jul. 31, 2018
Accounting Policies [Abstract]
Financial Information	This summary of significant accounting policies is presented to assist in understanding the Company's financial statements. The financial statements and notes are the responsibility of the Company's management. These accounting policies conform to accounting principles generally accepted in the United States of America ("US GAAP") and have been consistently applied in the preparation of the financial statements.
Organization	Organization Hartford Great Health Corp. (the "Company" or "Hartford Great Health Corp.") was organized under the laws of the State of Nevada on April 2, 2008. The Company has not yet realized revenues from its planned operations. Its plan was to develop photographic sharing and networking through its website PhotoAmigo.com. The Company has chosen July 31 as its fiscal year-end.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with US GAAP requires the Company's management to make estimates and assumptions that affect the amounts of assets and liabilities, the identification and disclosure of impaired assets and contingent liabilities at the date of the financial statements, and the reported amounts expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents For purposes of balance sheet classification and the statements of cash flows, the Company considers cash in banks, deposits in transit, and all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of temporary cash investments. On July 31, 2018, the Company did not have a concentration of credit risk since it had no temporary cash investments in bank accounts in excess of the FDIC insured amounts.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of July 31, 2018 and 2017. These financial instruments include cash, accounts payable, and advances from officers. Fair values are assumed to approximate carrying values for these financial instruments because they are short term in nature, or are receivable or payable on demand.
Capital Expenditures	Capital Expenditures Expenditures for capital assets are recorded at historical cost. Additions, improvements and major renewals are capitalized, while maintenance, repairs and minor renewals are expensed as incurred. When assets are retired or disposed of, the assets and related accumulated depreciation and amortization are removed from our general ledger, and the resulting gain or loss is reflected in the statement of operations. Depreciation of capital assets is provided over their estimated useful lives on a straight line basis.
Impairment of Long Lived Assets	Impairment of Long Lived Assets Hartford Great Health Corp. periodically reviews the carrying amount of long lived assets to determine whether current events or changes in circumstances warrant adjustments to such carrying amounts. If an impairment adjustment is deemed necessary, such loss is measured by the amount that the carrying value of such assets exceeds their fair value. Considerable management judgment is necessary to estimate the fair value of assets; accordingly, actual results could vary significantly from such estimates. Assets to be disposed of are carried at the lower of their financial statement carrying amount or fair value less costs to sell.
Income Taxes	Income Taxes Deferred income taxes are recorded for timing differences between items of income or expense reported in the financial statements and those reported for income tax purposes using the asset/liability method of accounting for income taxes. Deferred income taxes and tax benefits are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and for tax loss and credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company provides for deferred taxes for the estimated future tax effects attributable to temporary differences and carry-forwards when realization is more likely than not. If the Company concludes that it is more likely than not that some portion or all of the deferred tax asset will not be realized, the balance of deferred tax assets is reduced by a valuation allowance.
Revenue Recognition	Revenue Recognition Hartford Great Health Corp. recently commenced operations and has not yet generated revenues from operations. Revenues was expected to be derived principally from subscriptions to our website. In accordance with established guidance, Hartford Great Health Corp. plans to recognize revenue when the price is fixed or determinable, persuasive evidence of an arrangement exists, the service is performed and collectability of the amount is reasonably assured. Certain insignificant amounts collected during the development, testing, and implementation phases are recorded as a recovery of development expense.
Advertising costs	Advertising costs Advertising costs are expensed as incurred. No advertising costs were incurred during the twelve month periods ended July 31, 2018 or 2017.
Stock-based Compensation	Stock-based Compensation Hartford Great Health Corp. has no stock compensation plan and has not made any grants since inception, and, accordingly, has not recognized any stock-based compensation expense. Hartford Great Health Corp. plans to account for stock-based compensation in accordance with the fair value recognition provisions of US GAAP. Stock based compensation will be measured at the grant date based upon the estimated fair value of the award and the expense will be recognized over the required employee service period. The fair value of restricted stock grants will be estimated on the grant date based upon the fair value of the common stock.
Income (Loss) Per Share	Income (Loss) Per Share Basic earnings per share includes no dilution and is computed by dividing net income (or loss) by the weighted-average number of shares outstanding during the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of the Company, assuming the issuance of an equivalent number of common shares pursuant to options, warrants, or convertible debt arrangements. Diluted earnings per share is not shown for periods in which the Company incurs a loss because it would be anti-dilutive. Similarly, potential common stock equivalents are not included in the calculation if the effect would be anti-dilutive. Since inception, Hartford Great Health Corp. has not issued any potentially dilutive securities. During the twelve months ended July 31, 2018 and 2017, no potentially dilutive debt or equity instruments were issued or outstanding.
Recent Accounting pronouncements	Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results operations.

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Jul. 31, 2018
Income Tax Disclosure [Abstract]
Income Tax Valuation	Period Ending Estimated NOL carry-forward NOL expires Estimated tax benefit from NOL and other tax benefits (20%) Valuation allowance Change in valuation allowance Net tax asset July 31, 2017 $ 307,280 2037 $ 61,000 $ (61,000 ) $ (4,000 ) $ - July 31, 2018 $ 332,647 2038 $ 66,000 $ (66,000 ) $ (5,000 ) $ -
Income Tax Rate	2018 2017 Income tax benefit at statutory rate (20 %) (20 %) Deferred income tax valuation allowance 20 % 20 % Reported tax rate 0 % 0 %

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	Jul. 31, 2018	Jul. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ (332,647)	$ (307,281)

STOCKHOLDERS' EQUITY (Details N

STOCKHOLDERS' EQUITY (Details Narrative) - USD ($)	12 Months Ended
	Jul. 31, 2018	Jul. 31, 2017
Stockholders' equity (deficit):
Cash contribution from shareholders	$ 25,948	$ 21,180
Preferred stock, par value per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value per share	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	3,018,000	3,018,000
Common stock, shares outstanding	3,018,000	3,018,000
Additional paid in capital	$ 47,128

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($)	12 Months Ended
	Jul. 31, 2018	Jul. 31, 2017
Income Tax Disclosure [Abstract]
Estimated carry-forward	$ 332,647	$ 307,280
NOL expires	2,038	2,037
Estimated tax benefit from NOL and other tax benefits	$ 66,000	$ 61,000
Valuation allowance	(66,000)	61,000
Change in valuation allowance	(5,000)	(4,000)
Net tax asset	$ 0	$ 0

INCOME TAXES (Details 2)

INCOME TAXES (Details 2)	12 Months Ended
	Jul. 31, 2018	Jul. 31, 2017
Income Tax Disclosure [Abstract]
Income tax benefit at statutory rate	(20.00%)	(20.00%)
Deferred income tax valuation allowance	20.00%	20.00%
Reported tax rate	0.00%	0.00%

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	12 Months Ended
	Jul. 31, 2018	Jul. 31, 2017
Related Party Transactions [Abstract]
Amount borrowed from shareholders	$ 47,128
Interest on loans from shareholders	2.00%
Accrued interest expense on these notes	$ 0	$ 237
Contributions from related party shareholders and officers	25,948	$ 21,180
Forgiven of accrued expenses	$ 237

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Nov. 14, 2018	Jul. 31, 2018	Jul. 31, 2017
Stock issued during the period, value		$ 0	$ 0
Subsequent Event [Member] | CHINA
Stock issued during the period, Shares	96,982,000
Stock issued during the period, value	$ 1,940,000
Stock price	$ 0.02